Glycine Research

This systematic review comprehensively evaluated the effects of glycine supplementation across multiple physiological systems in human adults, analyzing 50 studies including 42 randomized controlled trials. The review organized findings by physiological system: nervous, musculoskeletal, cardiovascular, digestive, metabolic/endocrine, and immune.

The nervous system showed the most consistent positive results. In healthy populations, glycine (typically 3g before bed) improved subjective sleep quality, reduced sleep onset latency, and decreased next-day fatigue, though sample sizes were generally small. In psychiatric populations, glycine showed benefits for schizophrenia symptoms (as an adjunct to antipsychotics) and treatment-resistant OCD, with some evidence for improved cognitive function.

Results for other physiological systems were more mixed. Musculoskeletal studies showed some benefits for joint health and exercise recovery. Metabolic studies suggested modest improvements in glucose metabolism and insulin sensitivity. The authors concluded that while glycine shows promise across multiple domains, larger and more rigorous trials are needed to confirm benefits, particularly for non-neurological outcomes.

This review evaluates the potential of glycine supplementation as an ergogenic aid for physical performance and exercise recovery. The authors examine glycine's multiple physiological roles relevant to exercise: its involvement in creatine synthesis, collagen formation, antioxidant defense (as a glutathione precursor), anti-inflammatory signaling, and muscle protein synthesis.

The mechanistic rationale is compelling. Glycine modulates oxidative stress by serving as a precursor to glutathione, the body's primary intracellular antioxidant. It reduces exercise-induced inflammation through NF-κB inhibition and cytokine modulation. Glycine also stimulates muscle protein synthesis via mTOR pathway activation and is essential for collagen synthesis, supporting connective tissue repair after exercise. Some evidence suggests glycine may enhance peak power output and reduce blood lactic acid accumulation during high-intensity exercise.

However, the authors are transparent about the evidence gaps. The majority of studies demonstrating performance and recovery benefits come from animal models and cell culture experiments. Human clinical trials specifically testing glycine as an ergogenic aid are scarce and generally small. The review concludes that while the biological plausibility is strong, there is currently insufficient human evidence to recommend glycine specifically as a performance-enhancing supplement, and calls for larger, well-designed human trials.

This comprehensive review examines the molecular mechanisms underlying glycine's anti-inflammatory properties, positioning it as the smallest amino acid with outsized immunomodulatory effects. The authors systematically detail how glycine acts on multiple inflammatory pathways, making a case for its therapeutic potential across a range of inflammatory conditions.

At the molecular level, glycine inhibits NF-κB activation, the master transcription factor driving inflammatory gene expression. This leads to reduced production of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β, while simultaneously increasing the anti-inflammatory cytokine IL-10. Glycine also provides cytoprotection by suppressing necrosis and pyroptosis (inflammatory cell death), which are key drivers of tissue damage in chronic inflammatory conditions.

The review highlights glycine's effects across diverse cell types and tissues, including macrophages, neutrophils, hepatocytes, endothelial cells, and adipocytes. The authors discuss evidence from both animal models and human studies showing benefits in conditions involving chronic low-grade inflammation such as metabolic syndrome, obesity, liver disease, and cardiovascular disease. They emphasize glycine's excellent safety profile and low cost as practical advantages for clinical application.

This clinical trial from Baylor College of Medicine tested glycine + NAC (GlyNAC) supplementation in older adults. After 16 weeks, participants showed:

• Corrected glutathione deficiency
• Reduced oxidative stress
• Improved mitochondrial function
• Better physical function measures

The combination addresses age-related decline in glutathione synthesis by providing both precursors.

This mechanistic study demonstrated that glycine's sleep-promoting effects are mediated through NMDA receptors in the suprachiasmatic nucleus (SCN), the brain's master circadian clock.

Glycine administration caused peripheral vasodilation, leading to heat dissipation and a drop in core body temperature, a critical physiological signal for sleep initiation.

This study examined whether glycine could mitigate the effects of sleep restriction on next-day performance. Healthy volunteers had their sleep restricted to 5.5 hours, then received glycine or placebo.

Glycine significantly reduced fatigue and sleepiness, and improved psychomotor vigilance task performance the next day. The effects were attributed to improved sleep quality during the restricted sleep period.

This placebo-controlled crossover study examined the effects of glycine on sleep quality in volunteers who had been continuously unsatisfied with their sleep. Participants received 3g glycine or placebo before bed.

Glycine significantly improved subjective sleep quality, sleep efficacy, and reduced daytime sleepiness. Polysomnographic analysis showed glycine shortened latency to sleep onset.